
Telmilib Trio 40mg/10mg/6.25mg Tablet
Marketer
Libramed Pharmaceuticals Private Ltd
Salt Composition
Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)
Overview Telmilib Trio 40mg/10mg/6.25mg Tablet
Tri-Med Hypertension 40mg/10mg/6.25mg tablets combine three medications to effectively manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, thereby mitigating the risk of future strokes and heart attacks. Administer Tri-Med Hypertension with food, at the same time daily, and as directed by your physician. Continue treatment as prescribed; discontinuation may increase stroke or heart attack risk. This medication includes a diuretic, increasing urination; avoid dosing within four hours of bedtime. Consistent use is crucial for optimal results, even during periods of well-being, as hypertension often presents without symptoms. Common side effects may include ankle edema, headache, dizziness, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counteract potential dryness or weakness. Prior to initiating treatment, disclose any liver or kidney conditions, pregnancy, breastfeeding, or concurrent medications, particularly cardiovascular or hypertensive agents. Regular monitoring of blood pressure, renal function, electrolyte balance, and blood glucose levels is essential to ensure treatment efficacy and safety.
Primary Ingredients of Telmilib Trio 40mg/10mg/6.25mg Tablet
No text was provided to rewrite. Please provide the text you want me to rephrase.
Uses of Telmilib Trio 40mg/10mg/6.25mg Tablet
Elevated blood pressure
Major Benefits of Telmilib Trio 40mg/10mg/6.25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmilib Trio 40mg/10mg/6.25mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Telmilib Trio 40mg/10mg/6.25mg Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Increased blood uric acid
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Telmilib Trio 40mg/10mg/6.25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Telmilib Trio 40mg/10mg/6.25mg tablet whole; do not crush, chew, or break it. Administer this medicine with food.
How Telmilib Trio 40mg/10mg/6.25mg Tablet works:
Telmisartan, Cilnidipine, and Chlorthalidone, combined as Telmilib Trio 40mg/10mg/6.25mg tablets, offer a three-pronged approach to blood pressure management. Telmisartan, an angiotensin receptor blocker (ARB), and Cilnidipine, a calcium channel blocker (CCB), both promote vasodilation, reducing vascular resistance and thus blood pressure. The diuretic, Chlorthalidone, contributes by increasing urinary excretion of water and electrolytes, leading to reduced blood volume and further blood pressure reduction via enhanced vascular relaxation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Telmilib Trio 40mg/10mg/6.25mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Telmilib Trio 40mg/10mg/6.25mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Telmilib Trio 40mg/10mg/6.25mg Tablet for breastfeeding mothers is lacking. Seek medical advice from your physician.
DrivingUNSAFE
The combination tablet Telmilib Trio (40mg/10mg/6.25mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if experiencing these side effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmilib Trio 40mg/10mg/6.25mg tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally unsuitable for such patients.
LiverCAUTION
Patients with liver impairment should use Telmilib Trio 40mg/10mg/6.25mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Telmilib Trio 40mg/10mg/6.25mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Telmilib Trio 40mg/10mg/6.25mg Tablet :
Should you forget to take a Telmilib Trio 40mg/10mg/6.25mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Telmilib Trio 40mg/10mg/6.25mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
